Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways
详细信息 查看全文
- 作者：Lina Song (1) (2)
Hui Yang (1) (2)
Hong-Xia Wang (1) (2)
Cui Tian (1) (2)
Yu Liu (1) (2)
Xiang-Jun Zeng (1) (2)
Erhe Gao (3)
Yu-Ming Kang (4)
Jie Du (1) (2)
Hui-Hua Li (1) (2) - 关键词：Baicalein ; 12/15 ; Lipoxygenase ; Ischemia/reperfusion ; Cardiac injury ; Signaling pathway
- 刊名：Apoptosis
- 出版年：2014
- 出版时间：April 2014
- 年：2014
- 卷：19
- 期：4
- 页码：567-580
- 全文大小：2,899 KB
- 参考文献：1. Armstrong SC (2004) Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61:427鈥?36 CrossRef
2. Eefting F, Rensing B, Wigman J et al (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61:414鈥?26 CrossRef
3. Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53:31鈥?7 CrossRef
4. Kayama Y, Minamino T, Toko H et al (2009) Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure. J Exp Med 206:1565鈥?574 CrossRef
5. Yigitkanli K, Pekcec A, Karatas H et al (2013) Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke. Ann Neurol 73:129鈥?35 CrossRef
6. Guadall A, Orriols M, Alcudia JF, Cachofeiro V, Martinez-Gonzalez J, Rodriguez C (2011) Hypoxia-induced ROS signaling is required for LOX up-regulation in endothelial cells. Front Biosci (Elite Ed) 3:955鈥?67
7. van Leyen K, Kim HY, Lee SR, Jin G, Arai K, Lo EH (2006) Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37:3014鈥?018 CrossRef
8. Natarajan R, Nadler JL (2004) Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 24:1542鈥?548 CrossRef
9. Reilly KB, Srinivasan S, Hatley ME et al (2004) 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J Biol Chem 279:9440鈥?450 CrossRef
10. Taylor AM, Hanchett R, Natarajan R et al (2005) The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth. Arterioscler Thromb Vasc Biol 25:2069鈥?074 CrossRef
11. Woo AY, Cheng CH, Waye MM (2005) Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism. Cardiovasc Res 65:244鈥?53 CrossRef
12. Sexton A, McDonald M, Cayla C, Thiemermann C, Ahluwalia A (2007) 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1. FASEB J 21:2695鈥?703 CrossRef
13. Tsutsumi YM, Patel HH, Huang D, Roth DM (2006) Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice. Am J Physiol Heart Circ Physiol 291:H979鈥揌983 CrossRef
14. Zhang Y, Zeng Y, Wang M et al (2011) Cardiac-specific overexpression of E3 ligase Nrdp1 increases ischemia and reperfusion-induced cardiac injury. Basic Res Cardiol 106:371鈥?83 CrossRef
15. Gao E, Lei YH, Shang X et al (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107:1445鈥?453 CrossRef
16. Ha T, Hua F, Li Y et al (2006) Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 290:985鈥?94 CrossRef
17. Li HH, Kedar V, Zhang C et al (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Investig 114:1058鈥?071 CrossRef
18. Li HH, Willis MS, Lockyer P et al (2007) Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Investig 117:3211鈥?223 CrossRef
19. Xu CW, Zhang TP, Wang HX, Yang H, Li HH (2013) CHIP enhances angiogenesis and restores cardiac function after infarction in transgenic mice. Cell Physiol Biochem 31:199鈥?08 CrossRef
20. Yang K, Zhang TP, Tian C, Jia LX, Du J, Li HH (2012) Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin II-induced cardiac remodeling. Am J Hypertens 25:994鈥?001 CrossRef
21. Sakamoto M, Minamino T, Toko H et al (2006) Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy. Circ Res 99:1411鈥?418 CrossRef
22. Sano M, Minamino T, Toko H et al (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444鈥?48 CrossRef
23. Toko H, Takahashi H, Kayama Y et al (2010) Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy. Circulation 122:891鈥?99 CrossRef
24. Natarajan R, Yang DC, Lanting L, Nadler JL (2002) Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells. Endocrine 18:295鈥?01 CrossRef
25. Jin G, Arai K, Murata Y et al (2008) Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 39:2538鈥?543 CrossRef
26. Pidgeon GP, Tang K, Cai YL, Piasentin E, Honn KV (2003) Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. Cancer Res 63:4258鈥?267
27. Logue SE, Gustafsson AB, Samali A, Gottlieb RA (2005) Ischemia/reperfusion injury at the intersection with cell death. J Mol Cell Cardiol 38:21鈥?3 CrossRef
28. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH (2005) Molecular biology of apoptosis in ischemia and reperfusion. J Investig Surg 18:335鈥?50 CrossRef
29. Wen Y, Gu J, Vandenhoff GE, Liu X, Nadler JL (2008) Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. Am J Physiol Heart Circ Physiol 294:H1933鈥揌1938 CrossRef
30. Bowden RA, Ding ZM, Donnachie EM et al (2002) Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circ Res 90:562鈥?69 CrossRef
31. Feng Y, Zhao H, Xu X et al (2008) Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 295:H1311鈥揌1318 CrossRef
32. Gu J, Liu Y, Wen Y, Natarajan R, Lanting L, Nadler JL (2001) Evidence that increased 12-lipoxygenase activity induces apoptosis in fibroblasts. J Cell Physiol 186:357鈥?65 CrossRef
33. Gu J, Wen Y, Mison A, Nadler JL (2003) 12-lipoxygenase pathway increases aldosterone production, 3鈥?5鈥?cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cells. Endocrinology 144:534鈥?43 CrossRef
34. Li H, Gao F, Ma L et al (2012) Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta. J Cell Mol Med 16:1606鈥?617 CrossRef
35. Kuhn H, Romisch I, Belkner J (2005) The role of lipoxygenase-isoforms in atherogenesis. Mol Nutr Food Res 49:1014鈥?029 CrossRef
36. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915鈥?919 CrossRef
37. Zhang T, Yang D, Fan Y, Xie P, Li H (2009) Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways. Apoptosis 14:1245鈥?254 CrossRef
38. Baines CP, Molkentin JD (2005) STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 38:47鈥?2 CrossRef
39. Wen Y, Gu J, Liu Y, Wang PH, Sun Y, Nadler JL (2001) Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth. Circ Res 88:70鈥?6 CrossRef - 作者单位：Lina Song (1) (2)
Hui Yang (1) (2)
Hong-Xia Wang (1) (2)
Cui Tian (1) (2)
Yu Liu (1) (2)
Xiang-Jun Zeng (1) (2)
Erhe Gao (3)
Yu-Ming Kang (4)
Jie Du (1) (2)
Hui-Hua Li (1) (2)
1. Department of Pathology, Physiology and Pathophysiology, Beijing AnZhen Hospital the Key Laboratory of Remodeling-Related Cardiovascular Diseases, School of Basic Medical Sciences, Capital Medical University, Ministry of Education, No. 10 Xitoutiao You An Men, Beijing, 100069, China
2. Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, 100029, China
3. Center for Translational Medicine, Temple University School of Medicine, Philadelphia, 19140, USA
4. Department of Physiology and Pathophysiology Xi鈥檃n Jiaotong University Cardiovascular Research Center, Xi鈥檃n Jiaotong University School of Medicine, Xi鈥檃n, 710061, China - ISSN：1573-675X
文摘
12/15-Lipoxygenase (LOX) is a member of the LOX family that catalyzes the step from arachidonic acid to hydroxy-eicosatetraenoic acids (HETEs). Previous studies demonstrated that 12/15-LOX plays a critical role in the development of atherosclerosis, hypertension, heart failure, and other diseases; however, its role in myocardial ischemic injury was contraversal. Here, we investigated the inhibition of 12/15-LOX by baicalein on acute cardiac injury and dissected its molecular mechanism. In a mouse model of acute ischemia/reperfusion (I/R) injury, 12/15-LOX was significantly upregulated in the peri-infarct area surrounding the primary infarction. In cultured cardiac myocytes, baicalein suppressed apoptosis and caspase 3 activity in response to simulated ischemia/reperfusion (I/R). Moreover, administration of 12/15-LOX inhibitor, baicalein, significantly attenuated myocardial infarct size induced by I/R injury. Moreover, baicalein treatment significantly inhibited cardiomyocyte apoptosis, inflammatory responses and oxidative stress in the heart after I/R injury. The mechanisms underlying these effects were associated with the activation of ERK1/2 and AKT pathways and inhibition of activation of p38 MAPK, JNK1/2, and NF-kB/p65 pathways in the I/R-treated hearts and neonatal cardiomyoctes. Our data indicated that 12/15-LOX inhibitor baicalein can prevent myocardial I/R injury by modulation of multiple mechanisms, and suggest that baicalein could represent a novel therapeutic drug for acute myocardial infarction.